DNA mismatch repair protein MSH2 dictates cellular survival in response to low dose radiation in endometrial carcinoma cells

Cancer Letters

Volumn 335, Issue 1, 2013, Pages 19-25

  Martin, Lynn M ^a   Marples, Brian ^b   Davies, Anthony M ^a   Atzberger, Ann ^a   Edwards, Connla ^a   Lynch, Thomas H ^c   Hollywood, Donal ^a   Marignol, Laure ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Cell cycle arrest; DNA mismatch repair; Endometrial; G2 M; Hypersensitivity; Ionizing radiation; Low dose; MSH2

Indexed keywords

HISTONE H2AX; MRE11 PROTEIN; PROTEIN MSH2; RAD51 PROTEIN;

ARTICLE; CARCINOMA CELL; CELL CYCLE ARREST; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; ENDOMETRIUM CARCINOMA; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LOW ENERGY RADIATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION RESPONSE;

CARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; HISTONES; HUMANS; MUTS HOMOLOG 2 PROTEIN; RADIATION TOLERANCE; RECOMBINATIONAL DNA REPAIR;

EID: 84878427186     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.046     Document Type: Article

References (43)

1. Abuin A., Zhang H., Bradley A. Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations. Molecular and Cellular Biology 2000, 20:149-157.
2. Anthoney D.A., McIlwrath A.J., Gallagher W.M., Edlin A.R., Brown R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Resarch 1996, 56:1374-1381.
3. Bi X., Gong M., Srikanta D., Rong Y.S. Drosophila ATM and Mre11 are essential for the G2/M checkpoint induced by low-dose irradiation. Genetics 2005, 171:845-847.
4. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., Lindblom A., et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994, 368:258-261.
5. Brown K.D., Rathi A., Kamath R., Beardsley D.I., Zhan Q., Mannino J.L., Baskaran R. The mismatch repair system is required for S-phase checkpoint activation. Nature Genetics 2003, 33:80-84.
6. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., Weitzman M.D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. The EMBO Journal 2003, 22:6610-6620.
7. Chaturvedi P., Eng W.K., Zhu Y., Mattern M.R., Mishra R., Hurle M.R., Zhang X., Annan R.S., Lu Q., Faucette L.F., Scott G.F., Li X., Carr S.A., Johnson R.K., Winkler J.D., Zhou B.B. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999, 18:4047-4054.
8. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995, 82:321-330.
9. Deckbar D., Birraux J., Krempler A., Tchouandong L., Beucher A., Walker S., Stiff T., Jeggo P., Lobrich M. Chromosome breakage after G2 checkpoint release. Journal of Cell Biology 2007, 176:749-755.
10. Elliott B., Jasin M. Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells. Molecular Cell Biology 2001, 21:2671-2682.
11. Enns L., Bogen K.T., Wizniak J., Murtha A.D., Weinfeld M. Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis. Molecular Cancer Research 2004, 2:557-566.
12. Fernet M., Megnin-Chanet F., Hall J., Favaudon V. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity. DNA Repair (Amst) 2009, 9:48-57.
13. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993, 75:1027-1038.
14. Franchitto A., Pichierri P., Piergentili R., Crescenzi M., Bignami M., Palitti F. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase. Oncogene 2003, 22:2110-2120.
15. Hartwell L.H., Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science 1989, 246:629-634.
16. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000, 287:1824-1827.
17. Houtgraaf J.H., Versmissen J., van der Giessen W.J. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovascular Revascularization Medicine: Including Molecular Interventions 2006, 7:165-172.
18. Joiner M.C., Marples B., Lambin P., Short S.C., Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. International Journal of Radiation Oncology Biology Physics 2001, 49:379-389.
19. Karran P. Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 2001, 22:1931-1937.
20. Krueger S.A., Collis S.J., Joiner M.C., Wilson G.D., Marples B. Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser Activity. International Journal of Radiation Oncology Biology Physics 1981, 69(2007):1262-1271.
21. Krueger S.A., Joiner M.C., Weinfeld M., Piasentin E., Marples B. Role of apoptosis in low-dose hyper-radiosensitivity. Radiation Research 2007, 167:260-267.
22. Krueger S.A., Wilson G.D., Piasentin E., Joiner M.C., Marples B. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. International Journal of Radiation Oncology Biology Physics 2010, 77:1509-1517.
23. Leach F.S., Nicolaides N.C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomaki P., Sistonen P., Aaltonen L.A., Nystrom-Lahti M., et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993, 75:1215-1225.
24. Marples B., Collis S.J. Low-dose hyper-radiosensitivity: past, present, and future. International Journal of Radiation Oncology Biology Physics 2008, 70:1310-1318.
25. Marples B., Joiner M.C. The response of Chinese hamster V79 cells to low radiation doses: evidence of enhanced sensitivity of the whole cell population. Radiation Research 1993, 133:41-51.
26. Marples B., Wouters B.G., Joiner M.C. An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity: a plausible underlying mechanism?. Radiation Research 2003, 160:38-45.
27. Marquez N., Chappell S.C., Sansom O.J., Clarke A.R., Court J., Errington R.J., Smith P.J. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint. Oncogene 2003, 22:7642-7648.
28. Martin L., Marples B., Coffey M., Lawler M., Hollywood D., Marignol L. Recognition of O6MeG Lesions by MGMT and mismatch repair proficiency may be a Prerequisite for Low-dose radiation hypersensitivity. Radiation Research 2009, 172:405-413.
29. Martin L.M., Marples B., Coffey M., Lawler M., Lynch T.H., Hollywood D., Marignol L. DNA mismatch repair and the DNA damage response to ionizing radiation: Making sense of apparently conflicting data. Cancer Treatments Review 2010.
30. Matsuoka S., Huang M., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998, 282:1893-1897.
31. O'Brien V., Brown R. Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 2006, 27:682-692.
32. Renart J., Reiser J., Stark G.R. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. proceedings of the National Academy of Sciences USA 1979, 76:3116-3120.
33. Short S.C., Bourne S., Martindale C., Woodcock M., Jackson S.P. DNA damage responses at low radiation doses. Radiation Research 2005, 164:292-302.
34. Simonsson M., Qvarnstrom F., Nyman J., Johansson K.A., Garmo H., Turesson I. Low-dose hypersensitive gammaH2AX response and infrequent apoptosis in epidermis from radiotherapy patients. Radiotherapy and Oncology 2008, 88:388-397.
35. Stojic L., Brun R., Jiricny J. Mismatch repair and DNA damage signalling. DNA Repair (Amst) 2004, 3:1091-1101.
36. Surtees J.A., Alani E. Mismatch repair factor MSH2-MSH3 binds and alters the conformation of branched DNA structures predicted to form during genetic recombination. Journal of Molecular Biology 2006, 360:523-536.
37. Thomas C., Charrier J., Massart C., Cherel M., Fertil B., Barbet J., Foray N. Low-dose hyper-radiosensitivity of progressive and regressive cells isolated from a rat colon tumour: impact of DNA repair. International Journal Of Radiation Biology 2008, 84:533-548.
38. Turesson I., Nyman J., Qvarnstrom F., Simonsson M., Book M., Hermansson I., Sigurdardottir S., Johansson K.A. A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis. Radiotherapy And Oncology 2010, 94:90-101.
39. Umar A., Koi M., Risinger J.I., Glaab W.E., Tindall K.R., Kolodner R.D., Boland C.R., Barrett J.C., Kunkel T.A. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Research 1997, 57:3949-3955.
40. Villemure J.F., Abaji C., Cousineau I., Belmaaza A. MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks. Cancer Research 2003, 63:3334-3339.
41. Xue L., Yu D., Furusawa Y., Cao J., Okayasu R., Fan S. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions. International Journal Of Radiation Oncology Biology Physics 2009, 75:235-243.
42. Zhang Y., Rohde L.H., Wu H. Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repair. Current Genomics 2009, 10:250-258.
43. Zink D., Mayr C., Janz C., Wiesmuller L. Association of p53 and MSH2 with recombinative repair complexes during S phase. Oncogene 2002, 21:4788-4800.